Digital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Our content is fact checked by our senior editorial staff to reflect accuracy and ensure our readers get sound information and advice to make the smartest, healthiest choices.
We adhere to structured guidelines for sourcing information and linking to other resources, including scientific studies and medical journals.kickstarting our diet and workout routines. But while more time in the gym and counting calories may work for some, shedding stubborn pounds can be more difficult for others. That's whereoften come in. Novo Nordisk's diabetes drug Ozempic and its sister drug for weight loss, Wegovy, are the biggest names in the space right now—but the company isn't stopping there.
However, as of right now, the company is benefiting from Amycretin's stellar performance. After study results were announced, Novo Nordisk shares jumped 8 percent, Reuters reported. "We believe this data release is the primary driver for the shares," Barclays analysts said in a note, per theNovo Nordisk is also testing amylin in its weight-loss combination therapy CagriSema, which combines semaglutide with an amylin analog called cagrilintide. The treatment is being studied in a phase 3 trial, where it has shown greater weight loss and blood sugar control effects for patients with diabetes than those treated with one drug or the other.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Popularity of Ozempic's use for weight loss prompts new bill from New York City CouncilmemberDiabetes drugs like Ozempic have gained popularity for weight loss, but a New York City Council member is hoping to raise more awareness about side effects with a new bill.
Read more »
Crippling consequences over shortage of diabetes drug used for weight lossWhen we met him at his home in Covington, he was dealing with yet another message from yet another pharmacy telling him they did not have his type two diabetes drug in stock.
Read more »
Taking a weight-loss drug reduced a craving for opioidsEarly results from 20 people with opioid use disorder raise hopes that popular weight-loss drugs like Wegovy can tackle opioid addiction, too.
Read more »
Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug resultsZealand Pharma's Phase 2 trial was an 'uniquivocal win' for a drug that can treat both liver disease and obesity, analysts said.
Read more »
Ricki Lake Shows Off Her 30-pound Weight Loss In New PicFrancesca Gariano is a New York City-based freelance journalist reporting on culture, entertainment, beauty, lifestyle and wellness. She is a freelance contributor to TODAY.com, where she covers pop culture and breaking news.
Read more »
Eli Lilly's new ad says weight-loss drugs shouldn't be used out of 'vanity'In a new ad that nods to the 2024 Oscars, the pharmaceutical firm discourages people from using drugs like Mounjaro for cosmetic weight loss.
Read more »